Hepatology International
Overview
Hepatology International is a renowned peer-reviewed journal dedicated to advancing knowledge and understanding of liver diseases. It publishes high-quality research articles, reviews, and clinical studies, covering a wide range of topics including liver transplantation, viral hepatitis, alcoholic liver disease, and hepatocellular carcinoma. With its multidisciplinary approach, the journal serves as a valuable resource for hepatologists, gastroenterologists, and researchers worldwide, promoting the exchange of cutting-edge research and clinical practices in the field of hepatology.
Details
Details
Abbr.
Hepatol Int
Publisher
Springer
Start
2007
End
Continuing
Frequency
Quarterly
p-ISSN
1936-0533
e-ISSN
1936-0541
Country
United States
Language
English
Specialty
Gastroenterology
Metrics
Metrics
h-index / Ranks: 5603
65
SJR / Ranks: 1416
1813
CiteScore / Ranks: 1186
10.90
JIF / Ranks: 945
6.6
Recent Articles
1.
Cheah M, Crane H, George J
Hepatol Int
. 2025 Mar;
PMID: 40087205
Background: Metabolic Dysfunction-Associated Fatty Liver disease (MAFLD) among lean individuals is increasingly recognized. We aimed to compare the prevalence, metabolic characteristics, and outcomes of lean vs overweight/obese-MAFLD patients. Methods: Databases...
2.
Arai J, Okumura A, Kimoto S, Sakamoto K, Kitada T, Kitano R, et al.
Hepatol Int
. 2025 Mar;
PMID: 40085416
Objective: The proportion of non-B/non-C hepatocellular carcinoma cases is increasing, and the principal cause is metabolic dysfunction-associated steatotic liver disease (MASLD). The degree of intrahepatic natural killer (NK) cell infiltration...
3.
Zhang X, Zhang T, Wu F, Li Z, Xiao Z, Yu Z, et al.
Hepatol Int
. 2025 Mar;
PMID: 40063322
Background: A few studies focus on the long-term outcomes and surveillance strategies for patients with hepatocellular carcinoma (HCC) and microvascular invasion (MVI) who experience postoperative recurrence. The aim of this...
4.
Kim J, Kim H, Yoo J, Kim S, Kim Y
Hepatol Int
. 2025 Mar;
PMID: 40057630
Background: Despite numerous small-scale studies, the correlation between tenofovir alafenamide fumarate (TAF) and hyperlipidemia remains still limited. This study aims to evaluate the safety of TAF regarding hyperlipidemia and cardiovascular...
5.
6.
7.
8.
Ide K, Uchida H, Sakamoto S, Hayakawa I, Gautam V, Nakagawa S, et al.
Hepatol Int
. 2025 Mar;
PMID: 40029585
No abstract available.
9.
10.
Wang B, Zhuang S, Lin S, Lin J, Zeng W, Du B, et al.
Hepatol Int
. 2025 Feb;
PMID: 40019709
Background: Immune-mediated hepatotoxicity (IMH) induced by immune checkpoint inhibitors (ICIs) can lead to fatal outcomes. Exploring the risk factors associated with IMH is crucial for the early identification and management...